Location History:
- Jadavpur, IN (2020)
- Kolkata, IN (2016 - 2021)
Company Filing History:
Years Active: 2016-2021
Title: Dipyaman Ganguly: Innovator in Immune Modulation
Introduction
Dipyaman Ganguly is a prominent inventor based in Kolkata, India. He has made significant contributions to the field of immune modulation through his innovative research and patented inventions. With a total of three patents to his name, Ganguly is recognized for his work in developing compounds that target toll-like receptors, particularly TLR9.
Latest Patents
Ganguly's latest patents include groundbreaking inventions that focus on purine-based compounds and small molecule antagonists. The first patent, titled "Purine based compounds as toll-like receptor 9 antagonist," presents novel purine-based compounds that inhibit signaling through Toll-like receptors. These compounds are particularly useful in treating autoimmune diseases and inflammation where TLR9 activation is implicated.
The second patent, "Blocking toll-like receptor 9 signaling with small molecule antagonist," describes small molecule 4-(piperazin-1-yl)quinazolin-2-amino compounds. These compounds are designed to inhibit signaling by certain toll-like receptors, especially TLR9. The invention highlights the potential clinical applications of these compounds as pharmaceutical agents for treating conditions associated with unwanted immune activity due to TLR9 activation.
Career Highlights
Dipyaman Ganguly is affiliated with the Council of Scientific & Industrial Research, where he conducts his research and development activities. His work has garnered attention for its potential impact on the treatment of autoimmune diseases and related conditions.
Collaborations
Ganguly collaborates with notable colleagues, including Arindam Talukdar and Ayan Mukherjee. Their combined expertise contributes to the advancement of research in immune modulation and the development of innovative therapeutic solutions.
Conclusion
Dipyaman Ganguly's contributions to the field of immune modulation through his patented inventions demonstrate his commitment to advancing medical science. His work holds promise for improving treatment options for autoimmune diseases and enhancing our understanding of immune responses.